| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Bromadiolone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01616
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Bromadiolone inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
| Coumatetralyl |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01617
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Coumatetralyl inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
| Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde inhibits the expression of DME VKORC1L1 |
[2] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate inhibits the expression of DME VKORC1L1 |
[2] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Phenprocoumon |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00206
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Phenprocoumon inhibits the drug-metabolizing activity of DME VKORC1L1 |
[3] |
| Acenocoumarol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00513
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Acenocoumarol inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
| Fluindione |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00471
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Fluindione inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bisphenol A inhibits the expression of DME VKORC1L1 |
[4] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 4-hydroxycoumarin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00866
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
4-hydroxycoumarin inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
|
|
|
|
|
|